medigraphic.com
Instituto Nacional de Salud Pública

2003, Número S3

<< Anterior Siguiente >>

salud publica mex 2003; 45 (S3)


El Sistema Bethesda 2001

Bergeron C

Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 340-344
Archivo PDF: 79.95 Kb.


RESUMEN

El Sistema Bethesda es un sistema de terminología para informar los resultados de citología cervical. Se inició en 1988 y en la actualidad se usa en todos los Estados Unidos de América. Este sistema se actualizó en abril de 2001. Las modificaciones más import ntes son las siguientes: a) eliminación de la categoría “satisfactorio pero limitado por”, b) se reintegraron las modificaciones benignas en la categoría normal, c) la categoría “células escamosas atípicas de significado indeterminado” ahora se denomina “células escamosas atípicas”, y se subdivide en “células escamosas atípicas de significado indeterminado” y “no se puede excluir una lesión escamosa de alto grado”, y d) adenocarcinoma endocervical in situ, que ahora es una entidad separada. Las lesiones escamosas intraepiteliales de bajo y alto grado quedan sin cambios. Se proponen recomendaciones relacionadas con el uso de la revisión automatizada y la utilización de pruebas auxiliares.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262:931-934.

  2. The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 Bethesda Workshop. JAMA, 1992;267:1892.

  3. Davey DD, Nielsen ML, Rosenstock W, Kline TS.Terminology and specimen adequacy in cervicovaginal cytology: The College of American Pathologists’ interlaboratory comparison experience. Arch Pathol Lab Med 1992;116:903-907.

  4. Solomon D, Davey D, Kurman R, Moriarty A, O Connor D, Prey M et al. Terminology for reporting results of cervical cytology. JAMA 2002, 287, 2114-2119.

  5. Davey D, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: Current laboratory practices of participants in the College of American Pathologist interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2000;124:203-211.

  6. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.

  7. Quddus MR, Sung CJ, Steinhoff MM, et al. Atypical squamous metaplastic cells: Reproducibility, outcome, and diagnostic features on ThinPrep Pap test. Cancer. 2001;93:16-22.

  8. Sherman ME, Tabbara SO, Scott DR et al.”ASCUS, rule out HSIL”: Cytologic features, histologic correlates and human papillomavirus detection. Mod Pathol.1999;12:335-343.

  9. Sherman ME, Solomon D, Schiffman M, for the ALTS Group. Qualification of ASCUS: A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol.2001;116:386-394.

  10. Eddy GL, Stumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Biopsy findings in five hundred thirty one patients with atypical glandular cells of uncertain significance as defined by the Bethesda System.Am J Obstet Gynecol. 1997;177:1188-1195.

  11. Biscotti CV, Gero MA, Toddy SM, Fischler DF, Easley K. Endocervical adenocarcinoma in situ: An analysis of cellular features. Diagn Cytopathol. 1997;17:326-332.

  12. Lee KR, Manna EA, Jones MA.Comparative cytologic features of adenocarcinoma in situ of the uterine cervix. Acta Cytol. 1991;35:117-126.

  13. Soofer S, Sidawy M.Atypical glandular cells of undetermined significance: Clinically significant lesions and means of patient follow-up. Cancer. 2000;90:207-214.

  14. Montz FJ. Significance of “normal” endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol.2001;81:33-39.

  15. Ng ABP, Reagan JW, Hawliczek S, Wentz BW. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol.1974;18:356-361.

  16. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, for the 2001 ASCCP-sponsored Consensus Conference. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities JAMA.2002;287:2120-2129.

  17. Bergeron C, Jeannel D, Poveda JD, Cassonet P, Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000;95:821-827.

  18. Harris JE . Correspondence RE. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance : Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:950-951.

  19. The atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS) group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397-402.

  20. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB et al. Atypical glandular cells of undetermined significance: Cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-825.




2020     |     www.medigraphic.com